Myeung-su Lee

Iksan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study.

Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study.

Journal: Diagnostics (Basel, Switzerland)

Published: February 05, 2025

Vigeo Promotes Myotube Differentiation and Protects Dexamethasone-Induced Skeletal Muscle Atrophy via Regulating the Protein Degradation, AKT/mTOR, and AMPK/Sirt-1/PGC1α Signaling Pathway In Vitro and In Vivo.

Vigeo Promotes Myotube Differentiation and Protects Dexamethasone-Induced Skeletal Muscle Atrophy via Regulating the Protein Degradation, AKT/mTOR, and AMPK/Sirt-1/PGC1α Signaling Pathway In Vitro and In Vivo.

Journal: Nutrients

Published: July 12, 2024

Insights from the COVID-19 pandemic: underscoring the paramount value of patient education and counseling for rheumatic diseases.

Insights from the COVID-19 pandemic: underscoring the paramount value of patient education and counseling for rheumatic diseases.

Journal: Journal of rheumatic diseases

Published: October 13, 2023

Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.

Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.

Journal: The Korean journal of internal medicine

Published: May 08, 2023

The Korean College of Rheumatology: 40 Years of Public Health Influence.

The Korean College of Rheumatology: 40 Years of Public Health Influence.

Journal: Journal of rheumatic diseases

Published: December 01, 2021

Real-world experiences of the diagnosis process in Korean patients with ankylosing spondylitis based on a self-report questionnaire.

Real-world experiences of the diagnosis process in Korean patients with ankylosing spondylitis based on a self-report questionnaire.

Journal: The Journal of international medical research

Published: April 07, 2021

Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.

Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic.

Journal: The Korean journal of internal medicine

Published: August 12, 2020

Health-related Quality of Life Outcomes of Adalimumab for Patients With Rheumatoid Arthritis in Korea.

Health-related Quality of Life Outcomes of Adalimumab for Patients With Rheumatoid Arthritis in Korea.

Journal: Journal of rheumatic diseases

Published: June 29, 2020

Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.

Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial.

Journal: The Journal of international medical research

Published: June 27, 2020

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.

Journal: Rheumatology international

Published: May 05, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026